Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 2 de 2
Filtrar
Más filtros










Base de datos
Intervalo de año de publicación
1.
Clin J Gastroenterol ; 16(6): 937-941, 2023 Dec.
Artículo en Inglés | MEDLINE | ID: mdl-37658160

RESUMEN

Solid pseudopapillary neoplasm (SPN) is a rare pancreatic tumor that typically affects young women in the body and tail of the pancreas. SPN is often asymptomatic in the early stages, so it is initially discovered as a large tumor. In this report, we experienced a case of a relatively small SPN discovered in the setting of acute pancreatitis. Because there have been few reports of SPN being discovered in the situation like our case, we report this case based on a review of the literature.


Asunto(s)
Carcinoma Papilar , Neoplasias Pancreáticas , Pancreatitis , Humanos , Femenino , Pancreatitis/complicaciones , Pancreatitis/diagnóstico por imagen , Enfermedad Aguda , Páncreas/patología , Neoplasias Pancreáticas/diagnóstico , Neoplasias Pancreáticas/diagnóstico por imagen , Carcinoma Papilar/complicaciones , Carcinoma Papilar/diagnóstico , Carcinoma Papilar/cirugía
2.
Intern Med ; 61(21): 3233-3237, 2022 Nov 01.
Artículo en Inglés | MEDLINE | ID: mdl-35431306

RESUMEN

Regarding the prognosis of cases with advanced-stage hepatocellular carcinoma (HCC), a recent clinical study showed that the immune checkpoint inhibitors atezolizumab plus bevacizumab have superior efficacy to sorafenib. However, only a few reports have focused on their effects on extrahepatic metastases. We herein report a case of HCC in a 59-year-old man with intrahepatic lesions treated successfully by hepatic arterial chemoembolization, radiotherapy, and sorafenib; the extrahepatic lesion in the adrenal gland was treated by atezolizumab plus bevacizumab. The patient showed a tumor-free condition for one year. We have summarized the clinical course and reviewed the literature to underscore the efficacy of atezolizumab plus bevacizumab for treating extrahepatic lesions of HCC.


Asunto(s)
Neoplasias de las Glándulas Suprarrenales , Carcinoma Hepatocelular , Neoplasias Hepáticas , Masculino , Humanos , Persona de Mediana Edad , Carcinoma Hepatocelular/patología , Bevacizumab/uso terapéutico , Sorafenib/uso terapéutico , Neoplasias Hepáticas/patología , Neoplasias de las Glándulas Suprarrenales/diagnóstico por imagen , Neoplasias de las Glándulas Suprarrenales/tratamiento farmacológico , Neoplasias de las Glándulas Suprarrenales/secundario , Glándulas Suprarrenales/patología
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA